Clinical trial
Early Feasibility Study of Low Intensity Focused Ultrasound Neuromodulation in Patients With Fibromyalgia
NCT07934667 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Feasibility Study of Low Intensity Focused Ultrasound Neuromodulation in Patients With Fibromyalgia
- Lead sponsor
- University of Virginia
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 15, 2027
- Completion date
- April 1, 2029
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 2 arms.
-
Low Intensity Focused Ultrasound + Savoring Meditation (liFU+SM)
-
Low Intensity Focused Ultrasound
Primary endpoints
Registered primary outcome measures; 4 primary.
-
Safety of liFU intervention
Number of treatment-related unexpected adverse events and serious adverse events
-
Study recruitment rate
Number of participants enrolled divided by number screened.
-
Study adherence
Number of participants to complete all Phase 1 and Phase 2 intervention sessions
-
Study retention
Number of enrolled participants retained through the entirety of the study
Lead sponsor's other trials
University of Virginia, most recent start first.
+671 more trials See the organization page
Similar trials
Same condition (Fibromyalgia) and phase, most recent start first.
+685 more trials See the condition page